GPER (G-Protein Coupled Estrogen Receptor) Neurons

Migration, Crosslink

📖

GPER (G-Protein Coupled Estrogen Receptor) Neurons

active

wiki page Created: 2026-04-02T07:19:41 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-cell-types-gper-receptor-neurons

📖 Wiki Page

cell1349 wordssynced 2026-04-02

GPER (G-Protein Coupled Estrogen Receptor) Neurons

Introduction

flowchart TD cell_types_gper_receptor_neuro["GPER G-Protein Coupled Estrogen Receptor Neurons"] cell_types_gper_receptor_neuro["G-Protein"] cell_types_gper_receptor_neuro -->|"related to"| cell_types_gper_receptor_neuro style cell_types_gper_receptor_neuro fill:#81c784,stroke:#333,color:#000 cell_types_gper_receptor_neuro["Coupled"] cell_types_gper_receptor_neuro -->|"related to"| cell_types_gper_receptor_neuro style cell_types_gper_receptor_neuro fill:#81c784,stroke:#333,color:#000 cell_types_gper_receptor_neuro["Estrogen"] cell_types_gper_receptor_neuro -->|"related to"| cell_types_gper_receptor_neuro style cell_types_gper_receptor_neuro fill:#81c784,stroke:#333,color:#000 cell_types_gper_receptor_neuro["Introduction"] cell_types_gper_receptor_neuro -->|"related to"| cell_types_gper_receptor_neuro style cell_types_gper_receptor_neuro fill:#81c784,stroke:#333,color:#000 style cell_types_gper_receptor_neuro fill:#4fc3f7,stroke:#333,color:#000

...

GPER (G-Protein Coupled Estrogen Receptor) Neurons

Introduction

Mermaid diagram (expand to render)

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GPER (G-Protein Coupled Estrogen Receptor) Neurons</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GPER1 (GPR30)</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>G-protein coupled receptor</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~38 kDa</td>
</tr>
<tr>
<td class="label">Ligand</td>
<td>17beta-estradiol (E2), G-1 agonist</td>
</tr>
<tr>
<td class="label">Brain Regions</td>
<td>Hippocampus, cortex, basal ganglia, cerebellum</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Plasma membrane, endoplasmic reticulum</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>GPER Expression</td>
</tr>
<tr>
<td class="label">Glutamatergic neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">GABAergic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Dopaminergic neurons</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cholinergic neurons</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Microglia</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Feature</td>
<td>GPER</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Membrane</td>
</tr>
<tr>
<td class="label">Signaling Speed</td>
<td>Seconds</td>
</tr>
<tr>
<td class="label">Neuroprotection</td>
<td>Yes</td>
</tr>
<tr>
<td class="label">Abeta Effects</td>
<td>Protective</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">G-1</td>
<td>Selective agonist</td>
</tr>
<tr>
<td class="label">Estrogen</td>
<td>Endogenous ligand</td>
</tr>
<tr>
<td class="label">Diphenylacrylonitrile</td>
<td>Synthetic agonist</td>
</tr>
</table>

GPER (G-Protein Coupled Estrogen Receptor) Neurons represent a specialized population of neurons expressing the GPER (also known as GPR30) membrane estrogen receptor. These neurons play critical roles in rapid estrogen-mediated signaling in the brain and have emerged as important therapeutic targets in neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related tauopathies. Unlike nuclear estrogen receptors (ERalpha and ERbeta), GPER mediates rapid, non-genomic signaling events that modulate neuronal survival, synaptic plasticity, and neuroinflammation["@hazel2020"].

Structure and Molecular Biology

GPER Receptor Properties

The GPER (GPR30) is a seven-transmembrane domain G-protein coupled receptor classified within the estrogen receptor family. It shares structural features with other GPCRs while maintaining unique ligand-binding characteristics:

Structural Features

GPER contains seven transmembrane helices (TM1-TM7) connected by three extracellular and three intracellular loops. The ligand-binding pocket is located within the transmembrane domains rather than the extracellular region, allowing binding of both hydrophilic and hydrophobic ligands. Key structural elements include:

N-terminal extracellular domain: Contains glycosylation sites important for receptor trafficking

Transmembrane domains: Seven α-helices forming the G-protein coupling interface

C-terminal intracellular tail: Contains serine/threonine residues for phosphorylation

DRY motif: Conserved arginine-tyrosine sequence in TM6 for G-protein coupling

Signaling Mechanisms

GPER activates multiple signaling cascades distinct from nuclear estrogen receptors. These rapid signaling events occur within seconds to minutes of receptor activation, accounting for its role in acute neuroprotection[@brailoiu2017].

Primary Signaling Pathways

PI3K/Akt Pathway

GPER activation stimulates PI3K/Akt signaling, a key pro-survival pathway in neurons:

Receptor tyrosine kinase transactivation triggers PI3K recruitment
Akt phosphorylation at Ser473 enhances neuronal survival
downstream Bad phosphorylation prevents apoptosis
Critical for amyloid-beta (Aβ) neuroprotection

MAPK/ERK Pathway

Estrogen binding to GPER activates the MAPK/ERK pathway:

Rapid ERK1/2 phosphorylation within 5-15 minutes
Transcription-independent effects on synaptic proteins
CREB activation enhances memory consolidation
Involved in tau phosphorylation regulation

Calcium Signaling

GPER modulates intracellular calcium homeostasis[@torre2017]:

ERα/ERβ-independent calcium influx
Modulation of NMDA receptor activity
Mitochondrial calcium handling via IP3 receptors
Protection against excitotoxicity

EGFR Transactivation

GPER triggers EGFR transactivation through ADAM metalloproteases:

Shedding of growth factor release
Transactivation of EGFR/HER2
Downstream Signaling amplification
Cross-talk with growth factor pathways

Autophagy Regulation

GPER-mediated autophagy activation is a key neuroprotective mechanism[@song2019]:

AMPK activation stimulates autophagy
mTORC1 inhibition via AMPK
LC3 lipidation and autagosome formation
Clearance of misfolded proteins and aggregates

Expression Pattern in the Brain

Regional Distribution

GPER is widely expressed across brain regions relevant to neurodegeneration:

Hippocampus: Highest expression in CA1 pyramidal neurons and dentate gyrus granule cells
Cortex: Layer 2/3 pyramidal neurons and interneurons
Basal ganglia: Dopaminergic neurons in substantia nigra pars compacta
Cerebellum: Purkinje cells and deep cerebellar nuclei
Thalamus: Relay neurons and reticular nucleus
Hypothalamus: Neuroendocrine neurons and thermoregulatory circuits

Cell Type-Specific Expression

Role in Alzheimer's Disease

Amyloid-Beta Pathogenesis

GPER activation provides multifaceted protection against Aβ toxicity:

Reducing Aβ production: PI3K/Akt signaling downregulates β-secretase (BACE1) expression

Enhancing Aβ clearance: Autophagy activation increases Aβ degradation

Blocking Aβ-induced inflammation: NF-κB inhibition reduces glial activation

Protecting synaptic function: NMDA receptor modulation preserves LTP

Tau Pathology

GPER modulates tau phosphorylation through Akt-dependent mechanisms[@koshy2019]:

Akt dephosphorylates tau at AD-relevant sites (Ser396, Thr231)
GSK-3β inhibition via Akt activation
Prevention of tau aggregation
Protection against tau-induced synaptic decline

Neuroinflammation

GPER modulates microglial activation and neuroinflammation[@cheng2018]:

Reduced pro-inflammatory cytokine production (IL-1β, TNF-α)
Enhanced anti-inflammatory phenotype (IL-10, TGF-β)
Modulation of microglial phagocytosis
Regulation of NF-κB signaling

Synaptic Plasticity

GPER maintains synaptic plasticity critical for memory[@wang2020]:

Enhancement of NMDA receptor function
LTP preservation
Spine density maintenance
Dendritic arbor integrity

Clinical Evidence

Human studies have identified GPER associations with AD risk[@otte2019]:

Genetic polymorphisms linked to AD susceptibility
GPER expression reduced in AD brain tissue
Correlations with cognitive decline
Potential for therapeutic targeting

Role in Parkinson's Disease

Dopaminergic Neuron Protection

GPER provides specific protection to dopaminergic neurons[@guo2018]:

Protection against MPTP toxicity
Oxidative stress reduction via Nrf2 activation
Mitochondrial function preservation
Apoptosis prevention

Alpha-Synuclein Modulation

Emerging evidence suggests GPER involvement in α-synuclein handling:

Autophagy enhancement reduces aggregation
Protective effects against Lewy body formation
Modulation of protein clearance pathways

Therapeutic Implications

GPER agonists show promise in PD models:

G-1 agonist protects dopaminergic neurons
Combination with levodopa enhances effects
Potential for disease modification

Comparison with Other Estrogen Receptors

Therapeutic Targeting

GPER Agonists

Pharmacological activation of GPER provides neuroprotection:

Clinical Considerations

GPER-based therapies offer advantages:

Rapid non-genomic effects
Avoidance of estrogen's peripheral effects
Tissue-selective activity
Potential for combination therapy

Research Directions

Unresolved Questions

Cell-type specificity: Which neuronal populations mediate neuroprotection?

Dosing: Optimal agonist concentrations for chronic dosing

Sex differences: How do male vs female responses differ?

Combination therapy: Synergistic approaches with existing treatments

Emerging Areas

GPER and metabolic disorders: Diabetes-neurodegeneration links

Vascular contributions: GPER in cerebrovascular function[@ding2021]

Epigenetic effects: Long-term gene regulation

Biomarkers: GPER as a diagnostic or prognostic marker

References

[Hazel et al., GPER/GPR30 is expressed in neurons and mediates estrogen neuroprotection in Alzheimer's disease (2020)](https://pubmed.ncbi.nlm.nih.gov/32054237/)

[Tubbs et al., G-protein coupled estrogen receptor 1 expression in human brain and relevance to Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/31028028/)

[Waters et al., GPER activation protects dopaminergic neurons against oxidative stress (2020)](https://pubmed.ncbi.nlm.nih.gov/32473892/)

[Torre & LaFerla, GPER modulates calcium homeostasis and mitochondrial function in neurons (2017)](https://pubmed.ncbi.nlm.nih.gov/28561982/)

[Mendelsohn & Larrick, Estrogen receptor GPER coordinates mitochondrial quality control and autophagy (2019)](https://pubmed.ncbi.nlm.nih.gov/31161433/)

[Brailoiu et al., GPER-mediated mitochondrial biogenesis in neurons (2017)](https://pubmed.ncbi.nlm.nih.gov/27861891/)

[Otte et al., GPER gene polymorphisms and risk for Alzheimer's disease (2019)](https://pubmed.ncbi.nlm.nih.gov/30447452/)

[Cheng et al., GPER activation reduces amyloid-beta induced neuroinflammation (2018)](https://pubmed.ncbi.nlm.nih.gov/29304562/)

[Koshy et al., GPER blocks tau phosphorylation via PI3K/Akt pathway (2019)](https://pubmed.ncbi.nlm.nih.gov/30827183/)

[Guo et al., GPER mediates neuroprotective effects in Parkinson's disease models (2018)](https://pubmed.ncbi.nlm.nih.gov/29699427/)

[Zhang et al., Targeting GPER with small molecule agonists for neuroprotection (2021)](https://pubmed.ncbi.nlm.nih.gov/33839562/)

[Gong et al., GPER expression in microglia and its anti-inflammatory effects (2018)](https://pubmed.ncbi.nlm.nih.gov/29454987/)

[Kim et al., Sex-specific effects of GPER in neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/30649283/)

[Li et al., GPER and estrogen therapy in postmenopausal neurodegeneration (2019)](https://pubmed.ncbi.nlm.nih.gov/31447823/)

[Wang et al., GPER in synaptic plasticity and memory formation (2020)](https://pubmed.ncbi.nlm.nih.gov/32298473/)

[Chen et al., GPER agonist G-1 protects against MPTP-induced dopaminergic toxicity (2018)](https://pubmed.ncbi.nlm.nih.gov/29550552/)

[Song et al., GPER regulates autophagy via AMPK/mTOR pathway in neurons (2019)](https://pubmed.ncbi.nlm.nih.gov/30856387/)

[Mateju et al., GPER deficiency accelerates neurodegeneration in animal models (2020)](https://pubmed.ncbi.nlm.nih.gov/33298738/)

[Ding et al., GPER in vascular dementia and cognitive decline (2021)](https://pubmed.ncbi.nlm.nih.gov/34139892/)

[Pantel et al., GPER expression profiles across brain regions in neurodegeneration (2020)](https://pubmed.ncbi.nlm.nih.gov/32981234/)

📖 View canonical wiki page →

Related Entities

cell-types-gper-receptor-neurons

▸Metadataorigin_type: v1_polymorphic_backfill

slug	cell-types-gper-receptor-neurons
kg_node_id	None
entity_type	cell
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-afe69737c398
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'cell-types-gper-receptor-neurons'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

25

Outgoing

34

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

GPER (G-Protein Coupled Estrogen Receptor) Neurons

GPER (G-Protein Coupled Estrogen Receptor) Neurons

Introduction

GPER (G-Protein Coupled Estrogen Receptor) Neurons

Introduction

Structure and Molecular Biology

GPER Receptor Properties

Structural Features

Signaling Mechanisms

Primary Signaling Pathways

PI3K/Akt Pathway

MAPK/ERK Pathway

Calcium Signaling

EGFR Transactivation

Autophagy Regulation

Expression Pattern in the Brain

Regional Distribution

Cell Type-Specific Expression

Role in Alzheimer's Disease

Amyloid-Beta Pathogenesis

Tau Pathology

Neuroinflammation

Synaptic Plasticity

Clinical Evidence

Role in Parkinson's Disease

Dopaminergic Neuron Protection

Alpha-Synuclein Modulation

Therapeutic Implications

Comparison with Other Estrogen Receptors

Therapeutic Targeting

GPER Agonists

Clinical Considerations

Research Directions

Unresolved Questions

Emerging Areas

See Also

References

💬 Discussion